유럽 연합 -
불가리아어 -
EMA (European Medicines Agency)
inlyta
pfizer europe ma eeig - акситиниб - Карцином, бъбречна клетка - Инхибитори на протеинкиназы - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.